| scholarly article | Q13442814 |
| P50 | author | Edus H Warren | Q37842175 |
| Michael Boeckh | Q56072917 | ||
| P2093 | author name string | Hongwei Wang | |
| Barry E Storer | |||
| Paul J Martin | |||
| Lue Ping Zhao | |||
| Wenhong Fan | |||
| Xinyi Cindy Zhang | |||
| John A Hansen | |||
| Jason W Chien | |||
| P2860 | cites work | A comprehensive review of genetic association studies | Q22337119 |
| The interleukin-6 -174promoter polymorphism is associated with long-term kidney allograft survival | Q78351883 | ||
| Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation | Q78571369 | ||
| The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation | Q78630210 | ||
| The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation | Q79768217 | ||
| Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation | Q80001093 | ||
| Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation | Q80290390 | ||
| Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantation | Q81490638 | ||
| HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease | Q81628613 | ||
| Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination | Q82312167 | ||
| Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation | Q84390923 | ||
| Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
| Possible impact of MADCAM1 gene single nucleotide polymorphisms to the outcome of allogeneic hematopoietic stem cell transplantation | Q28238184 | ||
| Genotype imputation for genome-wide association studies | Q29614880 | ||
| Association of IL-10 and IL-10Rbeta gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor | Q33437907 | ||
| Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors | Q33747297 | ||
| Polymorphisms in the base excision repair pathway and graft-versus-host disease | Q34063337 | ||
| Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria | Q34707280 | ||
| Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation. | Q35224947 | ||
| Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor | Q35847781 | ||
| The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis | Q37385249 | ||
| Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation | Q40516766 | ||
| Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation | Q40689796 | ||
| Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation | Q44208126 | ||
| Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation | Q44241092 | ||
| IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease. | Q44440386 | ||
| Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation | Q44701671 | ||
| Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes | Q45096625 | ||
| Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia | Q46249991 | ||
| Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children | Q46297998 | ||
| Donor CD31 genotype and its association with acute graft-versus-host disease in HLA identical sibling stem cell transplantation. | Q46503118 | ||
| Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype | Q46683630 | ||
| Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate. | Q46976436 | ||
| Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation. | Q47762458 | ||
| Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation. | Q51785979 | ||
| Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. | Q51806981 | ||
| NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. | Q51819756 | ||
| Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease. | Q54505371 | ||
| Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia. | Q54586715 | ||
| HSP70-hom gene polymorphism as a prognostic marker of graft-versus-host disease. | Q55042638 | ||
| CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors | Q56901242 | ||
| Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation | Q58814550 | ||
| Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants | Q73205710 | ||
| Oestrogen receptor alpha gene polymorphism associates with occurrence of graft-versus-host disease and reduced survival in HLA-matched sib-allo BMT | Q73549317 | ||
| Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation | Q73552885 | ||
| Cytokine gene polymorphism in patients with graft-versus-host disease | Q73667963 | ||
| Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation | Q73832263 | ||
| Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation | Q74481774 | ||
| High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation | Q75197654 | ||
| Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants | Q77531846 | ||
| Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation | Q78016170 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | single-nucleotide polymorphism | Q501128 |
| P304 | page(s) | 5311-5319 | |
| P577 | publication date | 2012-01-26 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Evaluation of published single nucleotide polymorphisms associated with acute GVHD | |
| P478 | volume | 119 |
| Q37458669 | 16th IHIW: international histocompatibility working group in hematopoietic cell transplantation |
| Q35594106 | A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation |
| Q90374351 | A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms |
| Q87988396 | A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation |
| Q90005205 | Altered donor P2X7 activity in human leukocytes correlates with P2RX7 genotype but does not affect the development of graft-versus-host disease in humanised mice |
| Q91254517 | Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD |
| Q87995371 | Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples |
| Q39425522 | Association between single nucleotide polymorphisms of tumor necrosis factor gene and grade II-IV acute GvHD: a systematic review and meta-analysis |
| Q42376157 | Associations of interactions between NLRP3 SNPs and HLA mismatch with acute and extensive chronic graft-versus-host diseases |
| Q37159230 | Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors |
| Q36715943 | Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease |
| Q43441667 | Cytokine gene polymorphism and graft-versus-host disease: a survey in Iranian bone marrow transplanted patients |
| Q36543682 | Defining vulnerability in allogeneic transplants is more complicated than the two numerical digits of age |
| Q36305321 | Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT |
| Q37734489 | Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes |
| Q45853292 | Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host disease. |
| Q41108286 | Genetic risk factors for sclerotic graft-versus-host disease |
| Q35726310 | Genome-wide single-nucleotide polymorphism analysis revealed SUFU suppression of acute graft-versus-host disease through downregulation of HLA-DR expression in recipient dendritic cells |
| Q90841517 | Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation |
| Q33558113 | Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation |
| Q55045366 | Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence. |
| Q36712054 | Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations. |
| Q28080914 | Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime? |
| Q38258161 | Immunology of hematopoietic stem cell transplant. |
| Q40464375 | Impact of genomic risk factors on survival after haematopoietic stem cell transplantation for patients with acute leukaemia. |
| Q35564082 | Impact of inflammatory cytokine gene polymorphisms on developing acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation. |
| Q33774610 | Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target |
| Q38228079 | Interleukin-6 in renal disease and therapy. |
| Q33758318 | Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation |
| Q27002964 | Making the genomic leap in HCT: application of second-generation sequencing to clinical advances in hematopoietic cell transplantation |
| Q89965567 | Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD |
| Q45278539 | Microsatellite scanning of the immunogenome associates MAPK14 and ELTD1 with graft-versus-host disease in hematopoietic stem cell transplantation |
| Q33714011 | Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP. |
| Q35920698 | Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation |
| Q38502469 | Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome? |
| Q89102964 | Patient HLA Germline Variation and Transplant Survivorship |
| Q40692598 | Predicting survival using clinical risk scores and non-HLA immunogenetics. |
| Q33886907 | Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. |
| Q48355836 | Profile of Inflammation-Associated Proteins in Early Post-Transplant Samples of Patients After Allogeneic Hematopoietic Stem Cell Transplantation: a Preliminary Study |
| Q54186062 | Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. |
| Q34581495 | Recombinant structures expand and contract inter and intragenic diversification at the KIR locus |
| Q36931170 | Recursive organizer (ROR): an analytic framework for sequence-based association analysis |
| Q38623211 | Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant |
| Q40498649 | Replication of associations between genetic polymorphisms and chronic graft-versus-host disease |
| Q33642419 | Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation |
| Q38129337 | Role of non-HLA gene polymorphisms in graft-versus-host disease. |
| Q38068541 | Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation |
| Q52910705 | SNPs and prognosis of GvHD before HCT: any progress? |
| Q92580247 | Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading? |
| Q54965204 | The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation. |
| Q37169090 | The major histocompatibility complex: a model for understanding graft-versus-host disease |
| Q90601512 | Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease |
| Q49912604 | Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft versus host disease: low incidence of lower gastrointestinal tract disease |
| Q53761924 | Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation. |
| Q39175303 | Transplant genetics and genomics |
| Q40304463 | Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation |
Search more.